Inventor · disambiguated record
Iain Simpson
Also filed as: SIMPSON IAIN · SIMPSON IAIN DAVID
26 granted patents·30 pending applications·95 citations·filing 2003–2025
95Inventor score
Top patents by PatentIndex Score
56 records- 0195US11912727B2Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2023·Granted Feb 27, 2024·4 cites·13 claims
- 0294US12195485B2Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2022·Granted Jan 14, 2025·4 cites·23 claims
- 0391US9951068B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2017·Granted Apr 24, 2018·8 cites·21 claims
- 0491US9676769B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2014·Granted Jun 13, 2017·11 cites·9 claims
- 0591US9428498B2Substituted imidazo[4,5-c]pyridine compounds and compositions thereofPROXIMAGEN LTD·Filed 2014·Granted Aug 30, 2016·11 cites·16 claims
- 0690US10428066B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2018·Granted Oct 1, 2019·6 cites·25 claims
- 0789US11420984B2Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2019·Granted Aug 23, 2022·7 cites·19 claims
- 0888US10995091B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2018·Granted May 4, 2021·3 cites·14 claims
- 0986US10968223B2Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2020·Granted Apr 6, 2021·1 cites·24 claims
- 1085US10590125B2CompoundsPROXIMAGEN LLC·Filed 2016·Granted Mar 17, 2020·3 cites·9 claims
- 1185US10155761B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2017·Granted Dec 18, 2018·4 cites·16 claims
- 1284US11512082B2Substituted imidazo[4,5-c]pyridine compounds and compositions thereofPROXIMAGEN LLC·Filed 2020·Granted Nov 29, 2022·1 cites·20 claims
- 1383US9353086B2CXCR4 receptor antagonistsSAVORY EDWARD DANIEL·Filed 2011·Granted May 31, 2016·6 cites·17 claims
- 1483US7709471B2CompoundsASTRAZENECA AB·Filed 2007·Granted May 4, 2010·5 cites·6 claims
- 1582US2023110165A1Substituted Imidazo[4,5-c]pyridine Compounds and Compositions ThereofPROXIMAGEN LLC·Filed 2022·Application pending·0 cites
- 1682US2025313578A1Arginase Inhibitors and Methods of Use ThereofASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1781US9580415B2CompoundsPROXIMAGEN LTD·Filed 2014·Granted Feb 28, 2017·9 cites·20 claims
- 1880US10766897B2Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2019·Granted Sep 8, 2020·1 cites·27 claims
- 1978US8633318B2Compounds for treatment or prevention of inflammation, an inflammatory disease, or an immune or an autoimmune disorderSAVORY EDWARD DANIEL·Filed 2009·Granted Jan 21, 2014·3 cites·7 claims
- 2072US2022348577A1CXCR4 Receptor AntagonistsPROXIMAGEN LLC·Filed 2021·Application pending·0 cites
- 2167US11530208B2Imidazo[4,5-C]pyridine derived SSAO inhibitorsPROXIMAGEN LLC·Filed 2015·Granted Dec 20, 2022·1 cites·16 claims
- 2266US9150574B2Enzyme inhibitor compoundsEVANS DAVID·Filed 2011·Granted Oct 6, 2015·1 cites·12 claims
- 2365US9227967B2Inhibitor compounds of semicarbazide-sensitive amine oxidasesEVANS DAVID·Filed 2011·Granted Jan 5, 2016·1 cites·37 claims
- 2465US2025282800A1Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2025·Application pending·0 cites
- 2564US7138415B2Indolamid derivatives which possess glycogenphosphorylase inhibitory activityASTRAZENECA AB·Filed 2003·Granted Nov 21, 2006·3 cites·15 claims
- 2660US12435097B2Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2020·Granted Oct 7, 2025·0 cites·15 claims
- 2759US12503439B2Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Granted Dec 23, 2025·0 cites·35 claims
- 2859US7122567B2Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activityASTRAZENECA AB·Filed 2003·Granted Oct 17, 2006·2 cites·16 claims
- 2959US2012010188A1Imidazopyridine CompoundsNILSSON MARIANNE·Filed 2009·Application pending·0 cites
- 3058US2025388543A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3156US12410187B2Fused tricyclic compounds useful as anticancer agentsASTRAZENECA AB·Filed 2020·Granted Sep 9, 2025·0 cites·5 claims
- 3253US2016046606A1CXCR4 Receptor AntagonistsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 3353US2014206662A1Imidazopyridine CompoundsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 3452US2024254066A1Rescorcinols, methods for their manufacture, and uses thereofGW RES LTD·Filed 2022·Application pending·0 cites
- 3552US2014107150A1New Compounds IIPROXIMAGEN LTD·Filed 2013·Application pending·0 cites
- 3651US2010105655A1Novel compounds 515ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 3750US2024025858A1Cannabinoid derivatives as pharmaceutically active compounds and method of preparation thereofGW RES LTD·Filed 2021·Application pending·0 cites
- 3850US2011275678A1New Pyridine Derivatives as Leptin Receptor Modulator MimeticsHIGGINBOTTOM MICHAEL·Filed 2009·Application pending·0 cites
- 3949US2022267356A1Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 4049US2009312336A1Dihydropteridine compounds as anti proliferative agentsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 4148US2011118238A12-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disordersASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 4245US2006211760A1Indolamide derivatives which possess glycogen phosphorylase inhibitory activityASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 4344US2006264494A1Heterocyclic amide derivatives which process glycogen phorylase inhibitory activityASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 4444US2009203695A1Compounds IVBIOVITRUM AB·Filed 2008·Application pending·0 cites
- 4544US2011275638A1Piperazine derivatives and their use as leptin receptor modulatorsCHAPMAN EMMA·Filed 2009·Application pending·0 cites
- 4644US2011275670A1New Compounds VIICHAPMAN EMMA·Filed 2009·Application pending·0 cites
- 4743US2010137397A1Chemical CompoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4843US2015239905A1Imidazopyridine compoundsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 4942US2006199966A1Indol-2-amides as glycogen phosphorylase inhibitorsASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 5041US2011275637A1Piperazine derivatives and their use as leptin receptor modulatorsCHAPMAN EMMA·Filed 2009·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Iain Simpson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →